Clinical Trial Update: Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy [NA]

View source ↗

Summary

A completed clinical trial evaluating the effect of Angiotensin Converting Enzyme (ACE) inhibition on Cardiac Allograft Vasculopathy, with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Snippet

Sponsor: Stanford University | Conditions: Cardiac Allograft Vasculopathy | NA | Status: COMPLETED | Results posted: 2016-07-27